Duchenne Muscular Dystrophy has one of the most active rare disease trial programs, driven by drug treatment and gene therapy.
Active Trials
Total Trials
60 additional trials involve behavioral, dietary, diagnostic, or observational approaches.
69 trials are observational or have no phase designation.
Stay informed about clinical trials for Duchenne Muscular Dystrophy.
Follow this disease to get updates when trials open, close, or change status.
Already have an account? Sign in to manage your watchlists.
Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.
Last sync: March 15, 2026 at 9:00 PM